logo

For the Inventor, By the Inventor

Northampton, PA, United States of America

Daniel H S Lee

This inventor holds 3 USPTO granted patents. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel H S Lee. Retrieved from https://idiyas.com/inventor/daniel-h-s-lee-y4kenuqg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Northampton, PA (US) (2002)
  • Northhampton, PA (US) (2002 - 2006)

Company Filing History:

goldMedal3 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents

Years Active: 2002-2006

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7018797 - Method for treating neurodegenerative disorders (2006-03-28),
2. 6441049 - Method of treating neurodegenerative disorders via inhibition of amyloid beta peptide binding (2002-08-27),
3. 6407136 - 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor (2002-06-18),

Title: Innovations by Daniel H S Lee in Neurodegenerative Disorder Treatments

Introduction

Daniel H S Lee is an accomplished inventor based in Northampton, PA (US). He has made significant contributions to the field of neurodegenerative disorders, holding a total of 3 patents. His work focuses on innovative methods for treating conditions that affect cognitive function and overall brain health.

Latest Patents

Among his latest patents, one notable invention is a method for treating neurodegenerative disorders. This invention involves administering a compound that effectively inhibits the interaction of amyloid-beta with alpha-7 nicotinic acetylcholine receptors. Another significant patent is directed towards a similar method, emphasizing the inhibition of amyloid beta peptide binding to aid in the treatment of neurodegenerative disorders.

Career Highlights

Daniel H S Lee is currently associated with Ortho-McNeil Pharmaceutical Corporation, where he continues to advance research in the pharmaceutical field. His expertise and innovative approaches have positioned him as a key figure in developing treatments for complex neurological conditions.

Collaborations

He has collaborated with notable colleagues, including Allen B Reitz and Tina Morgan Ross, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Daniel H S Lee's work exemplifies the impact of innovative thinking in the treatment of neurodegenerative disorders. His patents reflect a commitment to improving patient outcomes through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…